These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39264189)

  • 21. Genotypic and phenotypic characterisation of a nosocomial outbreak of Candida auris in Spain during 5 years.
    Mulet-Bayona JV; Cancino-Muñoz I; Salvador-García C; Tormo-Palop N; Guna-Serrano MDR; Ferrer-Gómez C; Melero-García M; González-Candelas F; Gimeno-Cardona C
    Mycoses; 2024 Aug; 67(8):e13776. PubMed ID: 39086009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
    Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first invasive
    Tsai YT; Lu PL; Tang HJ; Huang CH; Hung WC; Tseng YT; Lee KM; Lin SY
    Emerg Microbes Infect; 2022 Dec; 11(1):1867-1875. PubMed ID: 35811508
    [No Abstract]   [Full Text] [Related]  

  • 26. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida auris - Comparison of sensititre YeastOne and Vitek 2 AST systems for antifungal susceptibility testing - A single centre experience.
    Patwardhan SA; Prayag PS; Soman RN; Purandare BD; Ramya S; Dawra R; Joshi R; Prayag AP
    Indian J Med Microbiol; 2024; 50():100618. PubMed ID: 38795936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in candidemia cases and emergence of fluconazole-resistant
    Siopi M; Georgiou PC; Paranos P; Beredaki MI; Tarpatzi A; Kalogeropoulou E; Damianidou S; Vasilakopoulou A; Karakosta P; Pournaras S; Meletiadis J
    Euro Surveill; 2024 Jul; 29(29):. PubMed ID: 39027938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.
    Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM
    Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.
    Desnos-Ollivier M; Bretagne S; Lortholary O; Dromer F;
    Antimicrob Agents Chemother; 2022 May; 66(5):e0172521. PubMed ID: 35412354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Molecular and Genetic Resistance Mechanisms in a Candida auris Isolate in a Tertiary Care Center in Türkiye.
    Erturk Sengel B; Ekren BY; Sayin E; Cerikcioglu N; Sezerman U; Odabasi Z
    Mycopathologia; 2023 Dec; 188(6):929-936. PubMed ID: 37639054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility.
    Williamson B; Wilk A; Guerrero KD; Mikulski TD; Elias TN; Sawh I; Cancino-Prado G; Gardam D; Heath CH; Govender NP; Perlin DS; Kordalewska M; Healey KR
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0162421. PubMed ID: 34633842
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of the
    Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
    Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
    Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity.
    Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L; Asadzadeh M
    PLoS One; 2020; 15(10):e0240426. PubMed ID: 33108361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal activity of nitroxoline against Candida auris isolates.
    Fuchs F; Hof H; Hofmann S; Kurzai O; Meis JF; Hamprecht A
    Clin Microbiol Infect; 2021 Nov; 27(11):1697.e7-1697.e10. PubMed ID: 34245904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal susceptibility pattern of Candida auris strains: Analysis of clinical strains in a tertiary-care educational university hospital.
    Khairy A; Hejres S; Elbahr U; Dayyab F; Delos Reyes CS; Pastrana JA; Vineeth C; Prem Sudha S; Keskin O; Singh Rana S; Fadel E; Erdem H; Sipahi OR
    New Microbiol; 2024 Jul; 47(2):152-156. PubMed ID: 39023524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
    Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.